Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 120 | 142 | +22 |
| Shares | 59.9M | 60.5M | +575.5K (+1.0%) |
| Value | $140.8M | $133.7M | −$7.12M (−5.1%) |
New holders (36)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (14)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Tang Capital Management LLC | 150,000 | $352.5K |
| Panagora Asset Management Inc | 140,318 | $329.7K |
| Cetera Advisor Networks LLC | 116,990 | $274.9K |
| Group One Trading, L.P. | 78,951 | $185.5K |
| Annandale Capital, LLC | 55,820 | $131.0K |
| State Board of Administration of Florida Retirement System | 37,970 | $89.2K |
| Walleye Capital LLC | 35,927 | $84.4K |
| Eagle Asset Management Inc | 20,423 | $48.0K |
| Two Sigma Securities, LLC | 16,864 | $39.6K |
| Bridgeway Capital Management, LLC | 14,100 | $33.1K |
| Whitener Capital Management, Inc. | 12,000 | $28.2K |
| O'Dell Group, LLC | 3,316 | $7.79K |
| Cutler Group LP | 700 | $1.00K |
| The PNC Financial Services Group, Inc. | 30 | $71 |